Tweets
- Tweets, page courante.
- Tweets & réponses
- Médias
Vous avez bloqué @BioNTech_Group
Êtes-vous sûr de vouloir voir ces Tweets ? Les voir ne débloquera pas @BioNTech_Group
-
Science or Art? A new publication about the potential of mRNA as therapeutic option for cancer in
@AAAS. The clinical trial is ongoing. https://www.science.org/toc/stm/13/610 pic.twitter.com/ESg3MyEGjj
Merci. Twitter en tiendra compte pour améliorer votre fil. SupprimerSupprimer -
Invited by the
@KenupFoundation, President@PaulKagame of Rwanda, President@Macky_Sall of Senegal, &@EU_Commission President@vonderleyen met#BioNTech CEO Uğur Şahin to discuss the establishment of vaccine manufacturing capabilities in the AU. https://investors.biontech.de/news-releases/news-release-details/joint-communique-biontech-evaluates-mrna-vaccine-manufacturing …pic.twitter.com/AgL7M8Z68S
Merci. Twitter en tiendra compte pour améliorer votre fil. SupprimerSupprimer -
We announced the signing of a letter of intent with Brazilian biopharmaceutical company Eurofarma Laboratórios to manufacture our
#COVID-19 vaccine for distribution within Latin America. This is an important step to broaden the access to vaccines. https://investors.biontech.de/news-releases/news-release-details/pfizer-and-biontech-announce-collaboration-brazils-eurofarma …pic.twitter.com/a428M4ets1
Merci. Twitter en tiendra compte pour améliorer votre fil. SupprimerSupprimer -
The
@US_FDA approved the Biologics License Application for our#mrna vaccine to prevent#COVID19 in individuals 16yrs & older.#BioNTech is the Marketing Authorization Holder in the U.S., making it the 1st COVID-19 vaccine granted approval by the FDA.https://edition.cnn.com/2021/08/23/health/fda-approval-pfizer-covid-vaccine/index.html …Merci. Twitter en tiendra compte pour améliorer votre fil. SupprimerSupprimer -
We want to make a difference for individuals and humankind. Our strategy remains focused on bringing our broad pipeline of Next-Generation Immunotherapies and
#vaccines to people worldwide to address#cancer and a growing list of infectious diseases: https://bit.ly/3AkyF10 pic.twitter.com/NBE8xvTfUF
Merci. Twitter en tiendra compte pour améliorer votre fil. SupprimerSupprimer -
Welcoming >50 new colleagues in Gaithersburg, MD! The 3rd acquisition in 14 months confirms our strategy of complementing organic growth through targeted acquisitions that expand our capabilities & accelerate the development of our immunotherapy pipeline.pic.twitter.com/we7zNrCM7y
Merci. Twitter en tiendra compte pour améliorer votre fil. SupprimerSupprimer -
“mRNA could be the next revolution in the biopharmaceutical landscape” said one of our co-founders Ugur Sahin and Özlem Türeci who joined
@TEDChris for a#tedmonterey talk about#COVID19. Learn more about our#mRNA technology and what’s next.https://bit.ly/3ih96I1Merci. Twitter en tiendra compte pour améliorer votre fil. SupprimerSupprimer -
We want to help eradicate Malaria. Therefore, we’re launching a project aimed and developing a well-tolerated and highly effective Malaria vaccine and implement sustainable vaccine supply solutions on the African continent. https://investors.biontech.de/news-releases/news-release-details/biontech-provides-update-plans-develop-sustainable-solutions …pic.twitter.com/MmEf8ZQ2XG
Merci. Twitter en tiendra compte pour améliorer votre fil. SupprimerSupprimer -
The recent flood disaster in Germany has a dramatic effect on a large number of people who've lost relatives, friends and homes. In solidarity, we will be donating 1 million € to the German Alliance for Disaster Relief (Aktionsbündnis Katastrophenhilfe). https://investors.biontech.de/news-releases/news-release-details/statement-biontechs-support-flood-hit-areas-north-rhine …pic.twitter.com/hOhzl3YlMQ
Merci. Twitter en tiendra compte pour améliorer votre fil. SupprimerSupprimer -
Our first manufacturing partner within the African Union has just been announced!
@biovac_inst is a Cape Town based biopharmaceutical company which will support the production of more than 100m doses of our#COVID19 vaccine as well as the distribution. https://investors.biontech.de/news-releases/news-release-details/pfizer-and-biontech-announce-collaboration-biovac-manufacture …pic.twitter.com/7dZ5HUdpiW
Merci. Twitter en tiendra compte pour améliorer votre fil. SupprimerSupprimer -
We want to help to bring this pandemic to an end. In light of the
#DeltaVariant, we have early added a new pillar to our comprehensive#COVID19 booster strategy – keeping us ahead of the COVID-19 virus. https://bit.ly/Booster-Update pic.twitter.com/CZPeGZt4FW
Merci. Twitter en tiendra compte pour améliorer votre fil. SupprimerSupprimer -
Vielen Dank an alle Referent:innen und Teilnehmer:innen des 1. mRNA-Kongresses von BioNTech. Ihre große Begeisterung für das Thema und die Diskussionen zeigen, dass wir gemeinsam auf dem richtigen Weg sind: aus der Pandemie zurück in ein normales Leben.pic.twitter.com/OSspN7g2Zu
Merci. Twitter en tiendra compte pour améliorer votre fil. SupprimerSupprimer -
We want to revolutionize cancer treatment and we continue to advance our pipeline: the first patient has been treated in our BNT111 randomized Phase 2 trial. BNT111 is the lead product candidate from our proprietary FixVac platform. https://investors.biontech.de/news-releases/news-release-details/biontech-announces-first-patient-dosed-phase-2-clinical-trial …pic.twitter.com/02NCQNDB10
Merci. Twitter en tiendra compte pour améliorer votre fil. SupprimerSupprimer -
We've reached a new milestone: We've manufactured 1bn doses of our
#mRNA based#Covid19 vaccine together with our partner@Pfizer. Our teams go above & beyond every day to bring the vaccine to as many people as possible around the world. Kudos to our colleagues!#TeamBioNTechpic.twitter.com/MBCc5mzcX9
Merci. Twitter en tiendra compte pour améliorer votre fil. SupprimerSupprimer -
Exzellenter Auftakt für den
#mRNA-Kongress am 12. Juni: Die Eröffnungskeynote hält Dr. Özlem Türeci Mitgründerin und CMO von#BioNTech. Jetzt anmelden unter: https://event.biontech.de/nocode . Die Teilnahme ist#kostenfrei für alle.pic.twitter.com/wypC3A1gTY
Merci. Twitter en tiendra compte pour améliorer votre fil. SupprimerSupprimer -
Addressing a pandemic requires global collaboration. As part of our pledge of 2bn doses to broaden access to our
#COVID12 vaccine, we’re providing 500m doses at a not-for profit price to the US for donation to ≈100 low- & lower middle-income countries. https://investors.biontech.de/news-releases/news-release-details/pfizer-and-biontech-provide-500-million-doses-covid-19-vaccine …pic.twitter.com/YPv5Kp6L6i
Merci. Twitter en tiendra compte pour améliorer votre fil. SupprimerSupprimer -
The
@EU_Commission expanded the conditional marketing authorization for our#COVID19 vaccine to incl. individuals 12-15rys of age. Our pediatric studies evaluating the safety & efficacy of our vaccine in children from the ages of 6mths - 11yrs are ongoing. https://investors.biontech.de/news-releases/news-release-details/pfizer-and-biontech-receive-first-authorization-european-union …pic.twitter.com/dkA81nLlYN
Merci. Twitter en tiendra compte pour améliorer votre fil. SupprimerSupprimer -
BioNTech SE a retweeté
We are working closely with our industrial partners to supply vaccines to low & middle income countries. They just pledged to make available 1.3 billion doses to these countries in 2021. 1 billion from
@BioNTech_Group@Pfizer 200 million from@JNJNews 100m from@Moderna_txMerci. Twitter en tiendra compte pour améliorer votre fil. SupprimerSupprimer -
We have published our first Sustainability Report. The publication is a milestone for us, showcasing not only the contribution we aspire to make to society through our innovative research, but also the wider responsibility we take on as a company. https://investors.biontech.de/static-files/7b130edf-10ca-47d7-aa27-d7afd9c5dae3 …pic.twitter.com/PNeHxONNFF
Merci. Twitter en tiendra compte pour améliorer votre fil. SupprimerSupprimer -
BioNTech SE a retweeté
Our new
contract 2021-2023 with @BioNTech_Group@Pfizer is now signed. It guarantees up to 1.8 billion doses for our fight against COVID and its variants. Contracts with other companies may follow, to protect Europe and the world in the long term. https://europa.eu/!cq33kC pic.twitter.com/3cI1isHLjl
Merci. Twitter en tiendra compte pour améliorer votre fil. SupprimerSupprimer
Le chargement semble prendre du temps.
Twitter est peut-être en surcapacité ou rencontre momentanément un incident. Réessayez ou rendez-vous sur la page Twitter Status pour plus d'informations.